Immuron
Carlton · Founded 1994
About Immuron
Immuron Ltd is a publicly listed Australian bio pharmaceutical Microbiome company focused on oral immunotherapy using polyclonal antibody products for humans. Immuron is a uniquely positioned company developing therapeutic products in NASH, ASH and other diseases mediated through gut disbiosis.
Company Facts
- Founded: 1994
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $32.2M
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2025)
- Ticker: asx:IMC
- Website: immuron.com
- Phone: +610398245254
Industries & Categories
Biopharma, Biotechnology, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/immuron-36211 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.